| 1 |
陈 琰，钱 频，袁 琳. 慢性阻塞性肺疾病肺外合并症的治疗现状和研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(1): 73-76.
|
| 2 |
McKinstry S, Singer J, Baarsma JP, et al. Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial[J]. Respirology, 2019, 24(11): 1081-1087.
|
| 3 |
Du Z, Huang X, Feng Y, et al. Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: A nationwide multicenter retrospective study[J]. Medicine (Baltimore), 2020, 99(26): 2083-2086.
|
| 4 |
黄潘文，张 平，方年新. 噻托溴铵对COPD患者痰液炎症细胞计数、炎症因子及MMP-9水平的影响[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 339-341.
|
| 5 |
Xu W, Wu J, Feng Y, et al. Comparison of the efficacy of aerosol inhalation between the ipratropium bromide and terbutaline on the patients with AECOPD[J]. Pak J Pharm Sci, 2019 , 32(5): 2489-249.
|
| 6 |
中华医学会，中华医学会杂志社，中华医学会全科医学分会，等. 慢性阻塞性肺疾病基层诊疗指南(2018年)[J]. 中华全科医师杂志，2018, 17(11): 856-870.
|
| 7 |
Piraino T. Noninvasive respiratory support in acute hypoxemic respiratory failure[J]. Respir Care, 2019, 64(6): 638-646.
|
| 8 |
Beltaief K, Msolli MA, Zorgati A, et al. Nebulized terbutaline and ipratropium bromide versus terbutaline alone in acute exacerbation of chronic obstructive pulmonary disease requiring noninvasive ventilation: A randomized double-blind controlled trial[J]. Acad Emerg Med, 2019, 26(4): 434-442.
|
| 9 |
Barrett R, Barrett R. Asthma and COPD medicines prescription-claims：A time-series analysis of England′s national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020)[J]. Expert Rev Respir Med, 2021, 15(12): 1605-1612.
|
| 10 |
江美芳，刘 蔺，秦 克. 噻托溴铵联合无创呼吸机治疗COPD合并Ⅱ型呼吸衰竭疗效及对患者血气指标和炎症因子的影响[J]. 标记免疫分析与临床，2020, 27(1): 132-135.
|
| 11 |
Cassambai S, Mee CJ, Renshaw D, et al. Tiotropium bromide, a long acting muscarinic receptor antagonist triggers intracellular calcium signalling in the heart[J]. Toxicol Appl Pharmacol, 2019, 384(1): 1147-1150.
|
| 12 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 13 |
许 俊，刘传枝. COPD并发肺炎血清内毒素、超敏CRP、IgM水平对病原体鉴别意义[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 50-52.
|
| 14 |
van Geffen WH, Carpaij OA, Westbroek LF, et al. Long-acting dual bronchodilator therapy (indacaterol/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trial[J]. Respir Med, 2020, 171(6): 106064.
|
| 15 |
王家珍，邹健金，胥春艳，等. 两种不同通气模式用于老年COPD合并Ⅱ型呼吸衰竭患者的疗效分析[J]. 川北医学院学报，2019, 34(4): 464-467.
|
| 16 |
Huang K, Guo Y, Kang J, et al. The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China[J]. Ther Adv Respir Dis, 2019, 13(8): 175-183.
|
| 17 |
Santus P, Franceschi E, Pini S, et al. Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation[J]. Pharmacol Res, 2021, 173(4): 1059-1065.
|
| 18 |
黄 霞，周 彪，龙 虎. 噻托溴铵与无创正压通气对老年COPD合并呼吸衰竭患者血气分析，炎症因子及APN, SOD, PAB水平的影响[J]. 国际呼吸杂志，2019, 39(5): 345-349.
|
| 19 |
Piraino T. Noninvasive respiratory support in acute hypoxemic respiratory failure[J]. Respir Care, 2019, 64(6): 638-646.
|
| 20 |
Duiverman ML, Vonk JM, Bladder G, et al. Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial[J]. Thorax, 2020, 75(3): 244-252.
|
| 21 |
刘晓曼，胡秀娟，国莉莉，等. 无创正压通气中SXX模式治疗对COPD合并Ⅱ型呼吸衰竭患者呼吸力学指标，肺功能及并发症的影响[J]. 解放军医药杂志，2021, 33(6): 59-62.
|
| 22 |
Spruit MA, Rochester CL, Pitta F, et al. Pulmonary rehabilitation, physical activity, respiratory failure and palliative respiratory care[J]. Thorax, 2019, 74(7): 693-699.
|